These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2838941)

  • 1. Decreased rate of growth of hepatocellular carcinoma recurrence after liver transplantation in patients maintained on cyclosporine immunosuppression.
    O'Grady JG; Johnson PJ; Zaman S; Calne RY; Williams R
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):394-6. PubMed ID: 2838941
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor size remains key for prediction of hepatocellular carcinoma recurrence after liver transplantation.
    Earl TM; Chapman WC
    Ann Surg Oncol; 2011 May; 18(5):1217-8. PubMed ID: 21327456
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant conversion to sirolimus in liver transplant patients with recurrent hepatocellular carcinoma - preliminary results.
    Kornberg A; Küpper B; Tannapfel A; Thrum K; Wilberg J; Bärthel E; Settmacher U
    Transpl Int; 2008 Jan; 21(1):96-9. PubMed ID: 17903182
    [No Abstract]   [Full Text] [Related]  

  • 4. Recurrence of hepatocellular carcinoma after liver transplantation presenting with massive intrahepatic bleeding.
    Donadon M; Giacomoni A; Lauterio A; Slim A; Pirotta V; Mangoni I; De Carlis L
    Liver Transpl; 2008 Feb; 14(2):259-61. PubMed ID: 18236411
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum -fetoprotein in hepatoma patients after liver transplantation.
    Alpert E; Starzl TE; Schur PH; Isselbacher KJ
    Gastroenterology; 1971 Aug; 61(2):144-8. PubMed ID: 4104962
    [No Abstract]   [Full Text] [Related]  

  • 6. Oesophageal metastases of hepatocellular carcinoma after liver transplantation.
    Kahn J; Kniepeiss D; Langner C; Wagner D; Iberer F; Tscheliessnigg K
    Transpl Int; 2010 Apr; 23(4):438-9. PubMed ID: 19761554
    [No Abstract]   [Full Text] [Related]  

  • 7. Selecting patients with hepatocellular carcinoma for transplantation.
    Piscaglia F; Gianstefani A; Righini R; Bolondi L
    Liver Transpl; 2007 Aug; 13(8):1203; author reply 1204. PubMed ID: 17663399
    [No Abstract]   [Full Text] [Related]  

  • 8. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
    Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver transplantation for hepatocellular carcinoma.
    Durand F; Belghiti J
    Hepatogastroenterology; 2002; 49(43):47-52. PubMed ID: 11941982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression.
    Vivarelli M; Cucchetti A; Piscaglia F; La Barba G; Bolondi L; Cavallari A; Pinna AD
    Liver Transpl; 2005 May; 11(5):497-503. PubMed ID: 15838913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hepatocellular carcinoma.
    Said A; Wells J
    Minerva Med; 2009 Feb; 100(1):51-68. PubMed ID: 19277004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of risk factors for recurrence of hepatocellular carcinoma after orthotopic liver transplantation.
    Lohmann R; Bechstein WO; Langrehr JM; Knoop M; Lobeck H; Keck H; Lemmems HP; Blumhardt G; Neuhaus P
    Transplant Proc; 1995 Feb; 27(1):1245-6. PubMed ID: 7533376
    [No Abstract]   [Full Text] [Related]  

  • 13. How should patients with hepatocellular carcinoma recurrence after liver transplantation be treated?
    Schwartz M; Roayaie S; Llovet J
    J Hepatol; 2005 Oct; 43(4):584-9. PubMed ID: 16120468
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantation.
    Roberts JP
    Liver Transpl; 2005 Nov; (11 Suppl 2):S45-6. PubMed ID: 16237702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocellular carcinoma.
    Reddy MS; Manas DM
    Transplantation; 2007 Feb; 83(3):367-8. PubMed ID: 17297420
    [No Abstract]   [Full Text] [Related]  

  • 16. Down-staging of hepatocellular carcinoma before liver transplantation: should we change our clinical practice?
    Ravaioli M; Grazi GL; Cescon M; Ercolani G; Pinna AD; Piscaglia F; Trevisani F
    Ann Surg; 2009 Aug; 250(2):348; author reply 348-9. PubMed ID: 19638902
    [No Abstract]   [Full Text] [Related]  

  • 17. Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation.
    Heckman JT; Devera MB; Marsh JW; Fontes P; Amesur NB; Holloway SE; Nalesnik M; Geller DA; Steel JL; Gamblin TC
    Ann Surg Oncol; 2008 Nov; 15(11):3169-77. PubMed ID: 18696158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
    Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downstaging hepatocellular carcinoma prior to liver transplantation.
    Gamblin TC; Geller DA
    Liver Transpl; 2005 Dec; 11(12):1466-8. PubMed ID: 16315292
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic transplantation.
    Calne R
    Springer Semin Immunopathol; 1980 Dec; 3(3):385-93. PubMed ID: 6267724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.